Nuclear receptor (NR) signaling is essential for normal development as well as normal metabolic and physiologic function in humans. In addition, NRs are potential targets in a variety of human diseases. Central to the action of NRs is their ability to recruit the transcriptional co-repressors, nuclear receptor co-represor (NCoR) and silencing mediator of retinoic acid and thyroid hormone receptors (SMRT), in the absence of ligand or in the presence of antagonists to target key pathways. In the following proposal we will use novel mouse models to understand how NCoR and SMRT specifically interact with target NRs in vivo. In particular we will focus on the thyroid hormone receptor (TR) and the liver x receptor (LXR) to understand the role of the co-repressors in vivo as we have determined already that NCoR can regulate their signaling. In the first Aim, we will determine if co-repressor specificity exists in vivo by analyzing the role of both NCoR and SMRT individually and together in context of thyroid hormone action in the liver. In the second Aim, we will focus on exploring the role of NCoR in both congenital hypothyroidism and resistance to thyroid hormone. Both of these human diseases are hypothesized to be due to aberrant co-repressor recruitment, though this has never been tested in vivo. In the third Aim, we will determine the role of NCoR in LXR-signaling both in the liver and in a variety of other key target issues. These studies will have direct applicability to the regulation of cholesterol metabolism in vivo. Interestingly, because LXR and TR intersect in the regulation of a number of key gene targets in cholesterol metabolism this Aim will also allow us to determine whether NCoR action is specific to a target NR. The completion of these three Aims will allow for greater comprehension of how modulation of co-repressor signaling in vivo alters key metabolic pathways. Furthermore this work should lead to novel insight into the target specificity of individual co-repressors and their role in key disease states that affect human health.

Public Health Relevance

The transcriptional co-repressors, NCoR and SMRT, have been hypothesized to play a key role in a variety of human diseases including leukemia, congenital hypothyroidism, resistance to thyroid hormone (RTH), metabolic inflammation and hormone-related cancers because of their ability to be recruited to nuclear receptors. By focusing on the role of these co-repressors in their interactions with the thyroid hormone receptors and the liver x receptor we will gain insight into the mechanism by which these co-repressors function in the whole animal. In addition, our studies should shed new light on congenital hypothyroidism, RTH and hypercholesterolemia as our approach will directly test the role of co-repressors in these diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK056123-12
Application #
8308005
Study Section
Special Emphasis Panel (ZRG1-EMNR-E (02))
Program Officer
Margolis, Ronald N
Project Start
2000-08-15
Project End
2014-07-31
Budget Start
2012-08-01
Budget End
2013-07-31
Support Year
12
Fiscal Year
2012
Total Cost
$360,885
Indirect Cost
$153,480
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02215
Hu, Yue; Semova, Ivana; Sun, Xiaowei et al. (2018) Fructose and glucose can regulate mammalian target of rapamycin complex 1 and lipogenic gene expression via distinct pathways. J Biol Chem 293:2006-2014
Hine, Christopher; Kim, Hyo-Jeong; Zhu, Yan et al. (2017) Hypothalamic-Pituitary Axis Regulates Hydrogen Sulfide Production. Cell Metab 25:1320-1333.e5
Mendoza, Arturo; Hollenberg, Anthony N (2017) New insights into thyroid hormone action. Pharmacol Ther 173:135-145
Vella, Kristen R; Hollenberg, Anthony N (2017) The actions of thyroid hormone signaling in the nucleus. Mol Cell Endocrinol 458:127-135
Mendoza, Arturo; Astapova, Inna; Shimizu, Hiroaki et al. (2017) NCoR1-independent mechanism plays a role in the action of the unliganded thyroid hormone receptor. Proc Natl Acad Sci U S A 114:E8458-E8467
Hollenberg, Anthony N (2016) The Endocrine Society Centennial: The Thyroid Leads the Way. Endocrinology 157:1-3
Kyono, Yasuhiro; Subramani, Arasakumar; Ramadoss, Preeti et al. (2016) Liganded Thyroid Hormone Receptors Transactivate the DNA Methyltransferase 3a Gene in Mouse Neuronal Cells. Endocrinology 157:3647-57
Goldfarb, Yael; Kadouri, Noam; Levi, Ben et al. (2016) HDAC3 Is a Master Regulator of mTEC Development. Cell Rep 15:651-665
Singh, Brijesh K; Sinha, Rohit A; Zhou, Jin et al. (2016) Hepatic FOXO1 Target Genes Are Co-regulated by Thyroid Hormone via RICTOR Protein Deacetylation and MTORC2-AKT Protein Inhibition. J Biol Chem 291:198-214
Shimizu, Hiroaki; Astapova, Inna; Ye, Felix et al. (2015) NCoR1 and SMRT play unique roles in thyroid hormone action in vivo. Mol Cell Biol 35:555-65

Showing the most recent 10 out of 34 publications